Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples

被引:29
|
作者
Porcelli, Stefano [1 ]
Kasper, Siegfried [2 ]
Zohar, Joseph [3 ,4 ]
Souery, Daniel [5 ,6 ]
Montgomery, Stuart [7 ]
Ferentinos, Panagiotis [8 ]
Rujescu, Dan [9 ]
Mendlewicz, Julien [10 ]
Pich, Emilio Merlo [7 ,11 ]
Pollentier, Stephane [12 ]
Penninx, Brenda W. J. H. [13 ,14 ]
Serretti, Alessandro [1 ]
机构
[1] Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy
[2] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria
[3] Sheba Med Ctr, Dept Psychiat, Tel Hashomer, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[5] Univ Libre Bruxelles, Lab Psychol Med, Brussels, Belgium
[6] Ctr Europeen Psychol Med, Psy Pluriel, Brussels, Belgium
[7] Imperial Coll Sch Med, London, England
[8] Athens Univ, Dept Psychiat, Med Sch, Athens, Greece
[9] Martin Luther Univ Halle Wittenberg, Univ Clin Psychiat Psychotherapy & Psychosomat, Halle, Germany
[10] Univ Libre Bruxelles, Brussels, Belgium
[11] Takeda Pharmaceut Int, Neurosci Therapeut Area Unit, Zurich, Switzerland
[12] Boehringer Ingelhe Pharma GmbH & Co KG, CNS Dis Res, Biberach, Germany
[13] Vrije Univ, Amsterdam UMC, Dept Psychiat, Amsterdam Neurosci, Amsterdam, Netherlands
[14] Vrije Univ, Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands
关键词
Social dysfunction; Schizophrenia; Mood disorders; Socio-demographic factors; Lifestyle factors; TREATMENT ENHANCEMENT PROGRAM; QUALITY-OF-LIFE; BIPOLAR DISORDER; RESISTANT DEPRESSION; ANTIPSYCHOTIC TRIALS; NEGATIVE SYMPTOMS; ADJUSTMENT SCALE; NATIONAL-INSTITUTE; CIGARETTE-SMOKING; MAJOR DEPRESSION;
D O I
10.1016/j.pnpbp.2019.109835
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Social dysfunction is a common symptom of several neuropsychiatric disorders. However, only in the last few years research began to systematically investigate clinical aspects of this relevant outcome. Interestingly, its distribution and link with other clinical variables is still unclear. This study investigated social dysfunction in 4 different cohorts of patients affected by mood disorders and schizophrenia to evaluate 1) the degree of social dysfunction in these populations; 2) the associations among social dysfunction and socio-demographic and psychopathological features. Methods: Data from 4 independent studies (CATIE, GSRD ES1, ES2 and ES3, STAR"D, STEP-BD) were investigated. Behavioural and affective indicators of social dysfunction were derived and operationalized from scales or questionnaire items related to the interaction with relatives, friends and significant people in patients affected by schizophrenia (N = 765) and mood disorders (N = 2278 + 1954 + 1829). In particular the social dysfunction indicator was derived from Sheehan Disability Scale (SDS) for GSRD sample, from the Work and Social Adjustment Scale (WSAS) for STAR*D sample, from the Life-Range of Impaired Functioning Tool (LRIFT) for STEP-BD sample, and from the Quality of Life Scale (QOLS) for CATIE sample. The distribution of social dysfunction was described and association with socio-demographic and psychopathological characteristics were analysed. Results: Social dysfunction indicators showed a broad distribution in all samples investigated. Consistently across studies, social dysfunction was associated with higher psychopathological severity (all samples except CATIE) and suicide risk (GSRD ES1 and ES2, STAR"D, and STEP-BD) that explain up to 47% of the variance, but also to lower education level (GSRD ES2, STAR"D, CATIE, and STEP-BD), poorer professional/work status (GSRD ES2 and ES3, STAR"D, CATIE, and STEP-BD), marital status (STAR*D and CATIE), age (younger age in GSRD ES1 and STAR"D, older age in CATIE), higher BMI (GSRD ES2 and ES3, and STEP-BD), and smoking (GSRD ES2 and ES3). Conclusion: Our results demonstrated that a significant percentage of patients affected by both mood disorders and schizophrenia shows relevant social dysfunction. Social dysfunction is related, but not completely explained by psychopathological severity. In several patients, it tends to persist also during remission state. Socio-demographic and lifestyle factors were also found to play a role and should therefore be taken into consideration in further studies investigating social dysfunction.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] REPEATED OBSERVATION OF ABNORMAL GYRIFICATION LOCALIZED TO THE FRONTOINSULAR CORTEX FROM FOUR INDEPENDENT SAMPLES WITH SCHIZOPHRENIA
    Palaniyappan, Lena
    James, Anthony
    Crow, Timothy J.
    Liddle, Peter F.
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S87 - S87
  • [22] Violent behaviour in schizophrenia - Retrospective study of four independent samples from Prague, 1949 to 2000
    Vevera, J
    Hubbard, A
    Vesely, A
    Papezova, H
    BRITISH JOURNAL OF PSYCHIATRY, 2005, 187 : 426 - 430
  • [23] Understanding immune system dysfunction and its context in mood disorders: psychoneuroimmunoendocrinology and clinical interventions
    Ortega, Miguel A.
    Fraile-Martinez, Oscar
    Garcia-Montero, Cielo
    Diaz-Pedrero, Raul
    Lopez-Gonzalez, Laura
    Monserrat, Jorge
    Barrena-Blazquez, Silvestra
    Alvarez-Mon, Miguel Angel
    Lahera, Guillermo
    Alvarez-Mon, Melchor
    MILITARY MEDICAL RESEARCH, 2024, 11 (01)
  • [24] Interpersonal & social rhythm therapy for mood symptoms in schizoaffective and other schizophrenia-spectrum disorders
    Bonfils, Kelsey
    Novick, Danielle
    BIPOLAR DISORDERS, 2021, 23 : 73 - 74
  • [25] The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders - A systematic review of magnetic resonance spectroscopy studies
    Reddy-Thootkur, Mounica
    Kraguljac, Nina Vanessa
    Lahti, Adrienne Carol
    SCHIZOPHRENIA RESEARCH, 2022, 249 : 74 - 84
  • [26] Replication of Han Chinese GWAS loci for schizophrenia via meta-analysis of four independent samples
    Xiao, Xiao
    Li, Ming
    SCHIZOPHRENIA RESEARCH, 2016, 172 (1-3) : 75 - 77
  • [27] THE ROYAL AUSTRALIAN AND NEW ZEALAND COLLEGE OF PSYCHIATRISTS CLINICAL PRACTICE GUIDELINE PROJECT AND CLINICAL PRACTICE GUIDELINES FOR ANXIETY DISORDERS, MOOD DISORDERS, SCHIZOPHRENIA AND RELATED DISORDERS
    Browne, M. Oakley
    Galletly, C.
    Andrews, G.
    Malhi, G.
    Carter, G.
    Hay, P.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 30 - 31
  • [28] Neurocognition and social skill in older persons with schizophrenia and major mood disorders: An analysis of gender and diagnosis effects
    Mueser, Kim T.
    Pratt, Sarah I.
    Bartels, Stephen J.
    Forester, Brent
    Wolfe, Rosemarie
    Cather, Corinne
    JOURNAL OF NEUROLINGUISTICS, 2010, 23 (03) : 297 - 317
  • [29] Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis
    Koskinen, Johanna
    Lohonen, Johanna
    Koponen, Hannu
    Isohanni, Matti
    Miettunen, Jouko
    SCHIZOPHRENIA BULLETIN, 2010, 36 (06) : 1115 - 1130
  • [30] The serotonin-2A receptor polymorphism and clinical symptoms in mood disorders, schizophrenia and alcohol dependence in Japan
    Terayama, H
    Takimoto, T
    Fukunishi, I
    Itoh, M
    Iwahashi, K
    ACTA NEUROPSYCHIATRICA, 2003, 15 (03) : 129 - 132